Please use this identifier to cite or link to this item:
http://dspace.bits-pilani.ac.in:8080/jspui/handle/123456789/13851
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Sundriyal, Sandeep | - |
dc.date.accessioned | 2024-01-17T04:42:16Z | - |
dc.date.available | 2024-01-17T04:42:16Z | - |
dc.date.issued | 2008-09 | - |
dc.identifier.uri | https://www.sciencedirect.com/science/article/pii/S0960894X08009505 | - |
dc.identifier.uri | http://dspace.bits-pilani.ac.in:8080/jspui/xmlui/handle/123456789/13851 | - |
dc.description.abstract | A new series of PPARγ ligands based on barbituric acid (BA) has been designed employing virtual screening and molecular docking approach. To validate the computational approach, designed molecules were synthesized and evaluated in in vitro radioligand binding studies. Out of the total 14 molecules, 6 were found to bind to the murine PPARγ with IC50 ranging from 0.1 to 2.5 μM as compared to reference standard, pioglitazone (IC50 = 0.7 μM). | en_US |
dc.language.iso | en | en_US |
dc.publisher | Elsevier | en_US |
dc.subject | Pharmacy | en_US |
dc.subject | PPARγ | en_US |
dc.subject | Virtual screening | en_US |
dc.subject | Docking | en_US |
dc.subject | Diabetes | en_US |
dc.subject | Barbituric acid | en_US |
dc.subject | Rosiglitazone | en_US |
dc.title | New PPARγ ligands based on barbituric acid: Virtual screening, synthesis and receptor binding studies | en_US |
dc.type | Article | en_US |
Appears in Collections: | Department of Pharmacy |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.